Mean age (years) |
Mean age (years) |
65,7+14,68
(26-93) |
Age (years) |
<65 |
20(37.7) |
|
>65 |
33 (63.3) |
Sex |
Male |
18(33.9) |
|
Female |
35(66.1) |
Body Mass Index |
Body Mass Index |
28.4+5.41(17.5-43,2) |
ASA Score |
1 |
8 (15) |
|
2 |
11(20.7) |
|
3 |
34(64.3) |
Comorbidity |
Comorbidity |
|
Hypertension |
Hypertension |
27(50.9) |
Artheriosclerotic Heard Disase (ASHD) |
Artheriosclerotic Heard Disase
(ASHD) |
26(49) |
Heart failure |
Heart failure |
20(37.7) |
Diabetes mellitus |
Diabetes mellitus |
17(32.1) |
Arrythemia |
Arrythemia |
11(20.7) |
Chronic Obstructive Pulmonary Disease (COPD) |
Chronic Obstructive
Pulmonary Disease (COPD) |
10(18.7) |
Chronic Kidney Failure (CKF) |
Chronic Kidney Failure (CKF) |
6(11.3) |
Cerebrovascular Accident (CVA) |
Cerebrovascular Accident (CVA) |
6(11.3) |
Cirhosis |
Cirhosis |
5(9.4) |
Pulmonary Embolism |
Pulmonary Embolism |
1(1.9) |
Malignancy history |
Malignancy history |
11(20.7) |
Previous abdominal surgery |
Previous abdominal surgery |
19(35.8) |
Anticoagulant treatment |
Warfarin |
16(30.1) |
|
Enoxaparin |
4(7.5) |
|
Apixaban |
1(1.9) |
|
Dabigatran |
1(1.9) |
Antiplatelet treatment |
Acetylsalicylic acid |
8(15.1) |
|
Clopidogrel |
1(1.9) |
|
Acetylsalicylic acid+ Clopidogrel |
4(7.5) |
Anticoagulant + antiplatelet treatment |
Anticoagulant + antiplatelet
treatment |
4(7.5) |
Indications for anticoagulant or
antiplatelet treatments
|
Cardiovascular diseases
|
29(54.7)
|
|
Cerebrovascular diseases |
3(5.7) |
|
Hematolojic diseases |
2(3.8) |
|
Malignancies |
1(1,9) |